Michael Calik

CalikPhD, Loyola University (Chicago)

Assistant Professor, Department of Biobehavioral Health Science, College of Nursing

Office: College of Nursing, Rm 740

Lab: College of Nursing, Rm 204

Phone: (312) 413-0581

email: mcalik@uic.edu

Web Site: Michael Calik Departmental  Page


Research Interests:

Michael W. Calik, PhD, is a neuroscientist studying breathing control during sleep. His future research will focus on developing novel and innovative treatments of sleep apnea, elucidating the afferent/efferent and peripheral/central neural circuitries of breathing and upper airway control, developing an animal autoimmune model of narcolepsy, and studying the effect of exercise on sleep apnea and inflammation.



Calik, M.W. & Carley, D.W. Intracerebroventricular injections of dronabinol, a cannabinoid receptor agonist, does not attenuate serotonin-induced apnea in Sprague-Dawley rats. J. Negative Results Biomed., 15 (2016) 8. (PMID: 27133202)

Calik, M.W. & Carley, D.W. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats. PLoS One, 9 (2014) e111412. (PMID: 25350456)

Weaver, T.E., Calik, M.W., Farabi, S.S., Fink, A.M., Galang-Boquiren, M.T., Kapella, M.K., Prasad, B., & Carley, D.W. Innovative treatments for adults with obstructive sleep apnea. Nat. Sci. Sleep, 2014(6) (2014) 137-147. (PMID: 25429246)

Calik, M.W., Radulovacki, M., & Carley, D.W. A method of nodose ganglia injection in Sprague-Dawley rat. J.Vis. Exp., 2014(93) (2014) e52233. (PMID: 25490160)

Calik, M.W., Radulovacki, M., & Carley, D.W. Intranodose ganglion injections of dronabinol attenuate serotonin-induced apnea in Sprague-Dawley rat. Resp. Physiol. Neurobiol., 190 (2014) 20-24. (PMID: 24121138)